Rhuematoid Arthritis (RA) and non-infused biologics: adherence, healthcare cost and utilization
Summary
This is a retrospective cohort study using MarketScan Commercial and Medicare Advantage files to examine medication adherence to RA non-infused biologics and the effect upon outcomes of healthcare costs, hospitalizations, and length of stay.
DATE PUBLISHED
September 18, 2023
FORMAT
Poster
AUTHORS
Francis Staskon, Edward A. Witt, Renee Baiano